Literature DB >> 10549133

Dynamics of stromelysin/inhibitor interactions studied by 15N NMR relaxation measurements: comparison of ligand binding to the S1-S3 and S'1-S'3 subsites.

P Yuan1, V P Marshall, G L Petzold, R A Poorman, B J Stockman.   

Abstract

This report describes the backbone amide dynamics of the uniformly 15N labeled catalytic domain of human stromelysin complexed to PNU-99533, a hydroxamate-containing ligand that binds to the S'1-S'3 region (right side) of the stromelysin active site, and to PNU-107859 and PNU-142372, both thiadiazole-containing ligands that bind to the S1-S3 region (left side) of the stromelysin active site. 15N R1, R2 and NOE NMR relaxation measurements were recorded and analyzed for each complex. Different dynamic behaviors were observed for stromelysin complexed to the two classes of ligands, indicating that it may be possible to use protein dynamics to distinguish between different binding orientations. In the absence of bound ligand at the S1-S3 subsites, the S1-S3 residues were found to be relatively rigid. In contrast, the S'1-S'3 subsites were found to be flexible in the absence of interactions with ligand. The relative rigidness of the S1-S3 subsites may be responsible for MMP binding specificity by discriminating between ligands of different shapes. By contrast, the inherent flexibility of the S'1-S'3 subsites allows structural rearrangement to accommodate a broad range of incoming substrates or inhibitors. Similarities and differences in dynamics observed for each complex provide insights into the interactions responsible for protein-ligand recognition. The relevance of protein dynamics to structure-based drug design is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549133     DOI: 10.1023/a:1008398807718

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  35 in total

1.  Changes in the NMR-derived motional parameters of the insulin receptor substrate 1 phosphotyrosine binding domain upon binding to an interleukin 4 receptor phosphopeptide.

Authors:  E T Olejniczak; M M Zhou; S W Fesik
Journal:  Biochemistry       Date:  1997-04-08       Impact factor: 3.162

Review 2.  Metalloproteinase inhibitors and the prevention of connective tissue breakdown.

Authors:  T E Cawston
Journal:  Pharmacol Ther       Date:  1996       Impact factor: 12.310

3.  Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity.

Authors:  A Morton; B W Matthews
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

4.  15N NMR relaxation studies of free and inhibitor-bound 4-oxalocrotonate tautomerase: backbone dynamics and entropy changes of an enzyme upon inhibitor binding.

Authors:  J T Stivers; C Abeygunawardana; A S Mildvan
Journal:  Biochemistry       Date:  1996-12-17       Impact factor: 3.162

5.  Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase.

Authors:  F J Moy; M R Pisano; P K Chanda; C Urbano; L M Killar; M L Sung; R Powers
Journal:  J Biomol NMR       Date:  1997-07       Impact factor: 2.835

6.  Solution structures of stromelysin complexed to thiadiazole inhibitors.

Authors:  B J Stockman; D J Waldon; J A Gates; T A Scahill; D A Kloosterman; S A Mizsak; E J Jacobsen; K L Belonga; M A Mitchell; B Mao; J D Petke; L Goodman; E A Powers; S R Ledbetter; P S Kaytes; G Vogeli; V P Marshall; G L Petzold; R A Poorman
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

7.  Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.

Authors:  J W Becker; A I Marcy; L L Rokosz; M G Axel; J J Burbaum; P M Fitzgerald; P M Cameron; C K Esser; W K Hagmann; J D Hermes
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

8.  The NMR structure of the inhibited catalytic domain of human stromelysin-1.

Authors:  P R Gooley; J F O'Connell; A I Marcy; G C Cuca; S P Salowe; B L Bush; J D Hermes; C K Esser; W K Hagmann; J P Springer
Journal:  Nat Struct Biol       Date:  1994-02

9.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation.

Authors:  N A Farrow; R Muhandiram; A U Singer; S M Pascal; C M Kay; G Gish; S E Shoelson; T Pawson; J D Forman-Kay; L E Kay
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

10.  13C NMR relaxation studies of backbone and side chain motion of the catalytic tyrosine residue in free and steroid-bound delta 5-3-ketosteroid isomerase.

Authors:  Q Zhao; C Abeygunawardana; A S Mildvan
Journal:  Biochemistry       Date:  1996-02-06       Impact factor: 3.162

View more
  8 in total

1.  Structure of neurolysin reveals a deep channel that limits substrate access.

Authors:  C K Brown; K Madauss; W Lian; M R Beck; W D Tolbert; D W Rodgers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

2.  Apparent tradeoff of higher activity in MMP-12 for enhanced stability and flexibility in MMP-3.

Authors:  Xiangyang Liang; A Arunima; Yingchu Zhao; Rajagopalan Bhaskaran; Anuradha Shende; Todd S Byrne; Jeremy Fleeks; Mark O Palmier; Steven R Van Doren
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

3.  Model-free analysis for large proteins at high magnetic field strengths.

Authors:  Shou-Lin Chang; Andrew P Hinck; Rieko Ishima
Journal:  J Biomol NMR       Date:  2007-06-26       Impact factor: 2.835

4.  Solution structure and backbone dynamics of an N-terminal ubiquitin-like domain in the GLUT4-regulating protein, TUG.

Authors:  M Cristina Tettamanzi; Chenfei Yu; Jonathan S Bogan; Michael E Hodsdon
Journal:  Protein Sci       Date:  2006-03       Impact factor: 6.725

5.  Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.

Authors:  Jacob D Durrant; César A F de Oliveira; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2011-06-20       Impact factor: 2.817

6.  Configurational entropy in protein-peptide binding: computational study of Tsg101 ubiquitin E2 variant domain with an HIV-derived PTAP nonapeptide.

Authors:  Benjamin J Killian; Joslyn Yudenfreund Kravitz; Sandeep Somani; Paramita Dasgupta; Yuan-Ping Pang; Michael K Gilson
Journal:  J Mol Biol       Date:  2009-04-09       Impact factor: 5.469

7.  Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.

Authors:  Jacob D Durrant; César Augusto F de Oliveira; J Andrew McCammon
Journal:  J Mol Recognit       Date:  2010 Mar-Apr       Impact factor: 2.137

8.  Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14.

Authors:  Emilie Buache; Robert Thai; Corinne Wendling; Fabien Alpy; Adeline Page; Marie-Pierre Chenard; Vincent Dive; Marc Ruff; Annick Dejaegere; Catherine Tomasetto; Marie-Christine Rio
Journal:  Cancer Med       Date:  2014-08-01       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.